Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain

Anniina T. Virtanen; Teemu Haikarainen; Parthasarathy Sampathkumar; Maaria Palmroth; Sanna Liukkonen; Jianping Liu; Natalia Nekhotiaeva; Stevan R. Hubbard; Olli Silvennoinen

doi:10.3390/ph16010075

Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain

Anniina T. Virtanen, Teemu Haikarainen, Parthasarathy Sampathkumar, Maaria Palmroth, Sanna Liukkonen, Jianping Liu, Natalia Nekhotiaeva, Stevan R. Hubbard, Olli Silvennoinen

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Article number	75
Journal	Pharmaceuticals
Volume	16
Issue number	1
Number of pages	17
ISSN	1424-8247
DOIs	https://doi.org/10.3390/ph16010075
Publication status	Published - Jan 2023
MoE publication type	A1 Journal article-refereed

Fields of Science

317 Pharmacy

Access to Document

10.3390/ph16010075Licence: CC BY

pharmaceuticals-16-00075Final published version, 2.28 MBLicence: CC BY

Cite this

@article{ada8cc8e33eb47db8d6c3ce07f54788e,

title = "Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain",

keywords = "JAK inhibitor, Jak2 v617f, Cytokine signaling, Myeloproliferative neoplasm, Pseudokinase, 317 Pharmacy",

author = "Virtanen, {Anniina T.} and Teemu Haikarainen and Parthasarathy Sampathkumar and Maaria Palmroth and Sanna Liukkonen and Jianping Liu and Natalia Nekhotiaeva and Hubbard, {Stevan R.} and Olli Silvennoinen",

year = "2023",

month = jan,

doi = "10.3390/ph16010075",

language = "English",

volume = "16",

journal = "Pharmaceuticals",

issn = "1424-8247",

publisher = "MOLECULAR DIVERSITY PRESERVATION INTERNATIONAL",

number = "1",

}

TY - JOUR

T1 - Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain

AU - Virtanen, Anniina T.

AU - Haikarainen, Teemu

AU - Sampathkumar, Parthasarathy

AU - Palmroth, Maaria

AU - Liukkonen, Sanna

AU - Liu, Jianping

AU - Nekhotiaeva, Natalia

AU - Hubbard, Stevan R.

AU - Silvennoinen, Olli

PY - 2023/1

Y1 - 2023/1

KW - JAK inhibitor

KW - Jak2 v617f

KW - Cytokine signaling

KW - Myeloproliferative neoplasm

KW - Pseudokinase

KW - 317 Pharmacy

U2 - 10.3390/ph16010075

DO - 10.3390/ph16010075

M3 - Article

C2 - 36678572

SN - 1424-8247

VL - 16

JO - Pharmaceuticals

JF - Pharmaceuticals

IS - 1

M1 - 75

ER -